Register for real-time alerts, custom portfolio, and market movers

Get Started

ADAP Adaptimmune Therapeutics PLC

0.98

0.0816 (9.08%)

After Hours

Last Updated: 17:02:21

Delayed by 15 minutes

Adaptimmune EPS beats by $0.19, beats on revenue

To read the full story on Seeking Alpha, click here.

Adaptimmune Therapeutics (NASDAQ:ADAP)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Adaptimmune Therapeutics Charts.

Adaptimmune Therapeutics (NASDAQ:ADAP)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Adaptimmune Therapeutics Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Adaptimmune Therapeutics PLC News

More Adaptimmune Therapeutics PLC News Articles

Canopus Biopharma (PK)

Nexus Energy Services (PK)

FuelCell Energy

Federal Home Loan Mortgage (QB)

Bell Buckle (PK)

Therapeutic Solutions (PK)

Impact Fusion (PK)

Strategic Asset Leasing (PK)

Anavex Life Sciences

GNCC Capital (CE)

Delayed Upgrade Clock